Isolation, characterization and clinical evaluation of a pancreas cancer-associated antigen.
A pancreas cancer-associated antigen (PCAA) was identified and isolated from ascites fluid of human pancreatic cancer. Purified PCAA was homogeneous as determined by polyacrylamide gel electrophoresis. PCAA was a glycoprotein with a molecular weight of approximately 1,000,000 and consisted of 20% carbohydrates and 80% peptides, had an isoelectric point of 4.7, and migrated to alpha 2-beta region. It possessed a sedimentation coefficient of 14S and appeared to be a fibrous or fibroglobular protein. Immunoreactivity of PCAA was sensitive to proteolytic enzymes, perchloric acid, KSCN, glycine-HCl at pH 2.5, urea and lithium diiodosalicylate; and insensitive to neuraminidase or beta-glucosidase. Immunohistochemical technique revealed that PCAA was located in the cytoplasm of ductal epithelial cells of malignant pancreas. Using heteroantiserum raised against purified PCAA, horseradish peroxidase and CNBr-activated Sepharose 4B, an enzyme-immunoassay (EIA) for circulating PCAA has been developed. From a group of 40 healthy blood donors, an upper limit of 16.2 micrograms of PCAA/ml of serum has been tentatively determined. An elevated PCAA was shown in 67% (29/43) of patients with pancreas cancer, as well as in 30% (11/36) of lung cancer patients, 27% (10/37) of colonic cancer patients, and in 16% (6/36) of breast cancer patients. The reactive antigen in sera of these cancers was shown to be immunologically identical. PCAA also was detected in extracts of various human tissues, particularly pancreatic tumors, colonic tumors, and in a normal colon. Further, PCAA exhibited heterogeneity in molecular weight, isoelectric point, and electrophoretic mobility.
D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis / Q000276:immunology / Q000302:isolation & purification*; D001202:Ascitic Fluid / Q000276:immunology; D001943:Breast Neoplasms / Q000276:immunology; D002845:Chromatography; D003110:Colonic Neoplasms / Q000276:immunology; D004591:Electrophoresis, Polyacrylamide Gel; D006023:Glycoproteins / Q000302:isolation & purification*; D006801:Humans; D007106:Immune Sera; D007122:Immunoelectrophoresis; D007124:Immunoenzyme Techniques; D008175:Lung Neoplasms / Q000276:immunology; D008970:Molecular Weight; D010190:Pancreatic Neoplasms / Q000276:immunology*; D011817:Rabbits / Q000276:immunology
D000951:Antigens, Neoplasm; D006023:Glycoproteins; D007106:Immune Sera; C031192:oncofetal antigens; C019454:pancreas-specific antigen